Table of Contents - Academy of Psychosomatic Medicine

More documents

Recommendations

Info

standardized assessment tools. In addition, minimal adverse effects were found. Further investigation with randomized, controlled clinical trials is necessary to firmly establish the effectiveness of oral ketamine for the treatment of depression and anxiety in patients receiving hospice care. Ketamine may be a promising safe, effective, and cost-effective treatment for depression and anxiety in this population. 8. A Blinded Retrospective Chart Review of the Efficacy of Methylphenidate vs. Other Treatments for Depression in Patients Receiving Hospice Care Presenting Author: Scott Irwin, MD, PhD Co-Authors: Steve Koh, MD, Laura Chambers, ASN, RN, Derek Koo, Dilip Jeste, MD, Joel Dimsdale, MD, FAPM Purpose: Depression in patients receiving hospice care is highly prevalent. Current pharmacological interventions do not work fast enough for these patients. A retrospective chart review of patients receiving inpatient hospice care who were diagnosed with a depressive disorder was conducted to determine the efficacy, time to efficacy, and safety of methylphenidate treatment vs. other treatments for depression. Methods: 80 consecutive charts of patients with a psychiatrist-made diagnosis of a depressive disorder were reviewed (preliminary analysis of the existing data are presented in the abstract). Reviewers blinded to treatments evaluated charts for severity of depression, global improvement, therapeutic effect, side effects, and efficacy of treatment based on the Clinical Global Impression Scale (CGI). Time to peak effect was also noted. CGI scores were compared for those patients who had received methylphenidate vs. those that had not by Mann–Whitney U testing. Time to peak effect will be evaluated by t-testing. Results: Stimulants exhibited a significantly better therapeutic effect than other treatments (2.33±0.23 vs. 3.06± .3; U=87, p
August and 169 for December; for suicide attempt, 56 for August and 32 for December). The number of consultation for depression and suicide attempt was significantly higher for the summer months compared to the winter months (p
Page 1 and 2: Poster Presentations Thursday, Nove
Page 3 and 4: 32. Paraneoplastic Encephalitis in
Page 5 and 6: 65. Alcoholics in the General Hospi
Page 7: 16. Phenomenology in Delirium and i
Page 10 and 11: days prior to their initial appoint
Page 14 and 15: to remission) in patients with majo
Page 16 and 17: viding more specific cutting scores
Page 18 and 19: Conclusions: The prevalence of depr
Page 20 and 21: Conclusion: Consider typical antips
Page 22 and 23: Results: The patient presented with
Page 24 and 25: Pilot Project: The website included
Page 26 and 27: Dworkin, R.H., “Pain insensitivit
Page 28 and 29: 48. The Influence of Patients’ La
Page 30 and 31: We encountered SMAS in the setting
Page 32 and 33: Conclusions: We hope to show that P
Page 34 and 35: 62. Fluoxetine-Induced Respiratory
Page 36 and 37: in the last 6 months). They answere
Page 38 and 39: mofetil (MMF) 1000 mg bid and tacro
Page 40 and 41: 77. Medical Inpatients’ Adherence
Page 42 and 43: These two cases demonstrate manifes
Page 44 and 45: ERRATA INSERT - ORAL PAPER SESSION
Page 46 and 47: The most important factors associat
Page 48 and 49: five-factor inventory and was admin
Page 50 and 51: moderate depression. Thus far, subj
Page 52 and 53: Methods: Findings from several stud
Page 54 and 55: 3. Capuron L, Gumnick JF, Musselman
Page 56 and 57: and should only be undertaken in a
Page 58 and 59: onset of disorder, particular depre
Page 60 and 61: NOTES 52
Page 62:
NOTES 54
show all

Table of Contents - Academy of Psychosomatic Medicine

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?